Story
BCE Stock Hits 52-Week Low on Ex-Dividend Date, Muted AI News

Summary
Shares of Canadian telecom giant BCE Inc. fell to a new 52-week low, pressured by the stock trading ex-dividend and a non-binding AI partnership with Cisco that failed to impress investors.
Shares of BCE Inc. (TSX:BCE) fell 1.3% in Tuesday trading, hitting a new 52-week low as the stock went ex-dividend and a strategic partnership announcement failed to provide a positive catalyst for the telecom giant.
Key Drivers of the Decline
The stock's decline was influenced by a combination of technical and fundamental factors. The two primary drivers for the session's weakness were:
- Ex-Dividend Date: The stock was trading ex-dividend for a cash distribution of CAD $0.312 per share. A stock's price typically drops by an amount roughly equal to the dividend on its ex-dividend date, creating mechanical downward pressure.
- Lukewarm Partnership Reception: Bell Canada, a BCE subsidiary, and Cisco announced a memorandum of understanding (MOU) to collaborate on a sovereign AI infrastructure. However, investors largely dismissed the news, as the non-binding agreement is seen as too early-stage to impact the company's near-term earnings narrative, according to Investing.com.
AdBroader Context and Headwinds
Tuesday's drop extended a prolonged downtrend for BCE, with the stock touching an intra-day low of $28.76, a stark contrast to its 52-week high of $36.25. The sustained selling pressure reflects persistent investor concerns over the company's performance and the macroeconomic environment.
Underlying worries include compression in average revenue per user (ARPU), stiff competition in the fibre infrastructure market, and uncertainty around BCE's strategic transition away from traditional telecom revenues. Furthermore, as a high-dividend-yielding company, BCE is particularly sensitive to rising interest rates. The current backdrop of elevated bond yields has diminished the relative appeal of income-oriented stocks for some investors.
Read next
More on Stocks
Praxis Options See Large Bullish Bet Ahead of Two FDA Decisions
A significant options trade on Praxis Precision Medicines suggests a trader is positioning for a substantial stock move ahead of two key FDA drug approval decisions slated for late 2026 and early 2027.

General Mills Appoints COO Dana McNabb as CEO to Succeed Jeff Harmening
The consumer goods company named 27-year veteran Dana McNabb its next chief executive, effective Jan. 1, as it navigates high inflation and competition from private-label brands.

Helsinki Benchmark Index Slips on Industrial and Financial Sector Weakness
Finland's OMX Helsinki 25 index closed down 0.55% on Wednesday, dragged lower by losses in the telecommunications, industrial, and financial sectors.

BEL 20 Index Falls to One-Month Low on Sector-Wide Weakness
Belgium's benchmark BEL 20 index fell 0.73% on Wednesday, hitting a new one-month low. The decline was driven by losses in the technology, financials, and consumer goods sectors, with Warehouses de Pauw NV leading the laggards.